INTERCEPT Blood System for Platelets
PMA: BP140143
Device Generic Name: Pathogen Reduction System for Platelets
Tradename: INTERCEPT Blood System for Platelets
Manufacturer: Cerus Corporation
Indications:
- The INTERCEPT Blood System for platelets is intended to be used for ex vivo preparation of pathogen-reduced Amicus apheresis platelet components suspended in 65% PAS-3/35% plasma, and Trima apheresis platelet components suspended in 100% plasma in order to reduce the risk of transfusion-transmitted infection (TTI), including sepsis, and as an alternative to gamma irradiation for prevention of transfusion-associated graft versus host disease (TA-GVHD).
Product Information
- Package Insert - INTERCEPT Blood System for Platelets - Small Volume (SV) Processing Set
- Package Insert - INTERCEPT Blood System for Platelets - Dual Storage (DS) Processing Set
- Package Insert - INTERCEPT Blood System for Platelets - Large Volume (LV) Processing Set
- Package Insert - INTERCEPT Blood System for Platelets –Small Volume (SV) Processing Set (Semi-Integrated Set)
- Package Insert - INTERCEPT Blood System for Platelets –Dual Storage (DS) Processing Set (Semi-Integrated Set)
- Package Insert - INTERCEPT Blood System for Platelets –Large Volume (LV) Processing Set (Semi-Integrated Set)